- $743.02m
- $1.20bn
- $370.24m
- 88
- 38
- 44
- 57
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 376 | 150 | 224 | 318 | 370 |
Cost of Revenue | |||||
Gross Profit | 89.2 | 103 | 166 | 244 | 290 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 370 | 142 | 224 | 320 | 348 |
Operating Profit | 6.39 | 7.77 | -0.012 | -2.44 | 22.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.386 | -3.77 | -7.22 | -18.2 | -3.85 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.563 | -0.979 | -7.84 | -23.2 | -2.65 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -3.04 | -0.419 | -4.46 | -17.1 | -0.811 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.04 | -0.419 | -4.46 | -17.1 | -0.811 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.29 | -0.004 | -0.155 | -0.746 | 0.089 |